Chemo plus immunotherapy for advanced penile cancer
Treatments studied
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a combination of two chemotherapy drugs (carboplatin and paclitaxel) plus the immunotherapy drug pembrolizumab (Keytruda) for penile cancer that has spread to nearby lymph nodes. The goal is to see if this combination can shrink or control the cancer before or after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have squamous cell carcinoma of the penis (a specific type of penile cancer).
- Your cancer has spread to lymph nodes in the groin or pelvis, or you have a lymph node that came back after previous treatment.
- You must be well enough to be up and about (ECOG score 0 or 1).
- You cannot have had prior treatment with a checkpoint inhibitor (like Keytruda).
- You must be able to provide a tumor tissue sample (biopsy) for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy drugs (paclitaxel, ifosfamide, cisplatin) and an immunotherapy drug (triplizumab) given before surgery for locally advanced penile cancer. The goal is to shrink the tumor and improve outcomes.
This trial tests a new combination treatment for advanced penile cancer that hasn't been treated before. It combines a targeted drug (becotatug vedotin) designed to attack cancer cells with an immunotherapy drug (pucotenlimab) that helps your immune system fight cancer.
This trial tests whether a maintenance drug called cemiplimab (an immunotherapy) can help keep your penile cancer from growing after you've finished platinum-based chemotherapy. It's a randomized study, so half the participants get cemiplimab and the other half get the best standard care, so doctors can compare which works better.
This trial tests a new approach to groin lymph node surgery in men with penile cancer. It aims to reduce side effects while still being effective.
This trial tests two drugs — becotatug vedotin and pucotenlimab — together in people with advanced penile cancer whose tumors show a protein called EGFR. It aims to see if this combination can shrink or slow the cancer.
This trial tests two drugs given before surgery for penile cancer that has spread to nearby tissues or lymph nodes. The goal is to see if this combination can shrink tumors and improve outcomes. The drugs work by helping the immune system attack cancer cells and delivering chemotherapy directly to them.
Hear when a new Urologic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.